Therefore, endothelial dysfunction and COVID-19-associated organ injury may in part be induced by increased angiotensin II at the cost of angiotensin 1–7 and increased bradykinin receptor B1 activity due to decreased ACE2 expression in endothelial cells. Here, ACE2 is linked to COVID-19.